WallStreetZenWallStreetZen

NASDAQ: SBFM
Sunshine Biopharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SBFM

Based on 1 analyst offering 12 month price targets for Sunshine Biopharma Inc

Min Forecast
$7.00+300%
Avg Forecast
$7.00+300%
Max Forecast
$7.00+300%

Should I buy or sell SBFM stock?

Based on 1 analyst offering ratings for Sunshine Biopharma Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SBFM stock forecasts and price targets.

SBFM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-08

1 of 1

Forecast return on equity

Is SBFM forecast to generate an efficient return?

Company
5.97%
Industry
184.14%
Market
261.14%
SBFM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SBFM forecast to generate an efficient return on assets?

Company
4.8%
Industry
103.6%
SBFM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SBFM earnings per share forecast

What is SBFM's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.85-118.73%
Avg 2 year Forecast
$0.34-92.55%

SBFM revenue forecast

What is SBFM's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$42.2M+16.23%
Avg 2 year Forecast
$61.2M+68.4%
SBFM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SBFM revenue growth forecast

How is SBFM forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
16.23%
Industry
3,347.39%
Market
1,348.83%
SBFM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SBFM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SBFM vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
SBFM$1.75$7.00+300.00%Strong Buy
EVOK$5.09N/AN/A
YCBD$0.88$2.00+127.27%Strong Buy
SNOA$3.95N/AN/A
IMCC$1.47N/AN/A
View Top Pharmaceutical Stocks

Sunshine Biopharma Stock Forecast FAQ

Is Sunshine Biopharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SBFM) stock is to Strong Buy SBFM stock.

Out of 1 analyst, 1 (100%) are recommending SBFM as a Strong Buy, 0 (0%) are recommending SBFM as a Buy, 0 (0%) are recommending SBFM as a Hold, 0 (0%) are recommending SBFM as a Sell, and 0 (0%) are recommending SBFM as a Strong Sell.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.

What is SBFM's earnings growth forecast for 2025-2026?

(NASDAQ: SBFM) Sunshine Biopharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 43,010.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,853.53%.

Sunshine Biopharma's earnings in 2025 is -$6,306,620.On average, 3 Wall Street analysts forecast SBFM's earnings for 2025 to be -$3,857,063, with the lowest SBFM earnings forecast at -$3,705,806, and the highest SBFM earnings forecast at -$3,970,506.

In 2026, SBFM is forecast to generate $1,533,531 in earnings, with the lowest earnings forecast at $1,473,393 and the highest earnings forecast at $1,578,635.

What is SBFM's revenue growth forecast for 2025-2026?

(NASDAQ: SBFM) Sunshine Biopharma's forecast annual revenue growth rate of 16.23% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3,347.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,348.83%.

Sunshine Biopharma's revenue in 2025 is $36,341,741.On average, 3 Wall Street analysts forecast SBFM's revenue for 2025 to be $192,438,561, with the lowest SBFM revenue forecast at $184,893,916, and the highest SBFM revenue forecast at $198,101,600.

In 2026, SBFM is forecast to generate $278,823,834 in revenue, with the lowest revenue forecast at $267,889,566 and the highest revenue forecast at $287,024,535.

What is SBFM's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: SBFM) forecast ROA is 4.8%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 103.6%.

What is SBFM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SBFM price target, the average SBFM price target is $7.00, with the highest SBFM stock price forecast at $7.00 and the lowest SBFM stock price forecast at $7.00.

The Wall Street analyst predicted that Sunshine Biopharma's share price could reach $7.00 by Oct 8, 2026. The average Sunshine Biopharma stock price prediction forecasts a potential upside of 300% from the current SBFM share price of $1.75.

What is SBFM's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: SBFM) Sunshine Biopharma's current Earnings Per Share (EPS) is $4.52. On average, analysts forecast that SBFM's EPS will be -$0.85 for 2025, with the lowest EPS forecast at -$0.81, and the highest EPS forecast at -$0.87. In 2026, SBFM's EPS is forecast to hit $0.34 (min: $0.32, max: $0.35).

What is SBFM's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: SBFM) forecast ROE is 5.97%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.